Gastric Cancer News and Research

RSS
LINE-1 jumping gene unusually active in gastrointestinal cancer

LINE-1 jumping gene unusually active in gastrointestinal cancer

Studies show jumping genes more active during development of gastrointestinal cancers

Studies show jumping genes more active during development of gastrointestinal cancers

Study reveals that miR-7 suppresses gastric cancer by inhibiting key signaling pathway

Study reveals that miR-7 suppresses gastric cancer by inhibiting key signaling pathway

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

Exalenz Bioscience, Galectin Therapeutics to use BreathID test to assess GR-MD-O2 efficacy in NASH Cirrhosis patients

Exalenz Bioscience, Galectin Therapeutics to use BreathID test to assess GR-MD-O2 efficacy in NASH Cirrhosis patients

Eradicating H. pylori bacterium with short course of therapy may help prevent gastric cancer

Eradicating H. pylori bacterium with short course of therapy may help prevent gastric cancer

Researchers identify five recurrent fusion genes involved in acute gastritis and cancer

Researchers identify five recurrent fusion genes involved in acute gastritis and cancer

Larrea Biosciences merged into Gordian Holdings

Larrea Biosciences merged into Gordian Holdings

AGA Research Foundation raises $10.5 million to support GI research

AGA Research Foundation raises $10.5 million to support GI research

New breath test could help diagnose oesophageal and gastric cancer in minutes

New breath test could help diagnose oesophageal and gastric cancer in minutes

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Researchers reveal that Helicobacter pylori infection can lead to gastric cancer

Researchers reveal that Helicobacter pylori infection can lead to gastric cancer

Scientists develop new technique to analyze bacterial populations

Scientists develop new technique to analyze bacterial populations

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Ariana Pharma joins the GastricGlycoExplorer consortium

Ariana Pharma joins the GastricGlycoExplorer consortium

FDA clears ADXS-HPV plus epacadostat IND for HPV-associated cervical cancer Phase 2 study

FDA clears ADXS-HPV plus epacadostat IND for HPV-associated cervical cancer Phase 2 study

Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

New study shows ulcer-causing bacteria can directly interact with stomach stem cells

New study shows ulcer-causing bacteria can directly interact with stomach stem cells

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH